# AleAnna, Inc.: financial statements, quarterly

ANNA · Nasdaq · CIK 1845123 · [Energy](/sectors/energy.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/anna.md) · [Financials](/companies/anna/financials.md) · [Filings](/companies/anna/filings.md) · [Insiders](/companies/anna/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/anna/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | [0.6](/filings/0001213900-25-109195.md) | [0.8 d](/filings/0001213900-26-036606.md) | [0.6](/filings/0001213900-26-056693.md) | [4.0](/filings/0001213900-26-088660.md) | [11.2](/filings/0001213900-25-109195.md) | [9.1 d](/filings/0001213900-26-036606.md) | [9.3](/filings/0001213900-26-056693.md) | [10.2](/filings/0001213900-26-088660.md) |
| Cost of revenue | $m | not reported | not reported | not reported | not reported | not reported | not reported | [0.8](/filings/0001213900-26-056693.md) | [0.3](/filings/0001213900-26-088660.md) | not reported | not reported | [1.6](/filings/0001213900-26-056693.md) | [1.5](/filings/0001213900-26-088660.md) |
| Operating income | $m | [(0.9)](/filings/0001213900-24-097353.md) | [(2.5) d](/filings/0001213900-25-026222.md) | [(2.1)](/filings/0001213900-25-044162.md) | [(1.0)](/filings/0001213900-25-076606.md) | [(1.5)](/filings/0001213900-25-109195.md) | [(10.0) d](/filings/0001213900-26-036606.md) | [(3.6)](/filings/0001213900-26-056693.md) | [0.6](/filings/0001213900-26-088660.md) | [5.7](/filings/0001213900-25-109195.md) | [0.2 d](/filings/0001213900-26-036606.md) | [3.7](/filings/0001213900-26-056693.md) | [1.9](/filings/0001213900-26-088660.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | not reported | not reported | [(0.0)](/filings/0001213900-26-056693.md) | [0.1](/filings/0001213900-26-088660.md) | [0.6](/filings/0001213900-25-109195.md) | [0.7 d](/filings/0001213900-26-036606.md) | [0.4](/filings/0001213900-26-056693.md) | [(1.7)](/filings/0001213900-26-088660.md) |
| Net income | $m | [0.3](/filings/0001213900-24-097353.md) | [0.5 d](/filings/0001193125-24-083443.md) | [(0.1)](/filings/0001213900-24-097353.md) | [(0.4)](/filings/0001213900-24-097353.md) | [(0.1)](/filings/0001213900-24-097353.md) | [(11.9) d](/filings/0001213900-26-036606.md) | [(2.0)](/filings/0001213900-26-056693.md) | [0.3](/filings/0001213900-26-088660.md) | [5.3](/filings/0001213900-25-109195.md) | [0.3 d](/filings/0001213900-26-036606.md) | [2.1](/filings/0001213900-26-056693.md) | [2.4](/filings/0001213900-26-088660.md) |
| Diluted EPS | $ per share | not reported | not reported | [(3.41)](/filings/0001213900-25-044162.md) | not reported | not reported | not reported | [(0.05)](/filings/0001213900-26-056693.md) | [0.01](/filings/0001213900-26-088660.md) | [0.08](/filings/0001213900-25-109195.md) | not reported | [0.05](/filings/0001213900-26-056693.md) | [0.06](/filings/0001213900-26-088660.md) |
| Basic EPS | $ per share | not reported | not reported | [(3.41)](/filings/0001213900-25-044162.md) | not reported | not reported | not reported | [(0.05)](/filings/0001213900-26-056693.md) | [0.01](/filings/0001213900-26-088660.md) | [0.08](/filings/0001213900-25-109195.md) | not reported | [0.05](/filings/0001213900-26-056693.md) | [0.06](/filings/0001213900-26-088660.md) |

- Revenue: us-gaap:Revenues
- Cost of revenue: us-gaap:CostOfRevenue
- Operating income: us-gaap:OperatingIncomeLoss
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss, us-gaap:ProfitLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [0.1](/filings/0001193125-23-281655.md) | [6.8](/filings/0001213900-26-036606.md) | [0.0](/filings/0001193125-24-142919.md) | [0.0](/filings/0001213900-24-073913.md) | [0.0](/filings/0001213900-24-097353.md) | [28.3](/filings/0001213900-26-056693.md) | [27.8](/filings/0001213900-26-056693.md) | not reported | [31.2](/filings/0001213900-25-109195.md) | [31.8](/filings/0001213900-26-088660.md) | [31.1](/filings/0001213900-26-056693.md) | [32.6](/filings/0001213900-26-088660.md) |
| Current assets | $m | [0.2](/filings/0001193125-23-281655.md) | [6.8](/filings/0001213900-25-026222.md) | [0.0](/filings/0001193125-24-142919.md) | [0.0](/filings/0001213900-24-073913.md) | [0.0](/filings/0001213900-24-097353.md) | [31.2](/filings/0001213900-26-036606.md) | [29.2](/filings/0001213900-25-044162.md) | [27.4](/filings/0001213900-25-076606.md) | [36.5](/filings/0001213900-25-109195.md) | [36.6](/filings/0001213900-26-088660.md) | [37.9](/filings/0001213900-26-056693.md) | [41.7](/filings/0001213900-26-088660.md) |
| Total assets | $m | [24.3](/filings/0001193125-23-281655.md) | [33.7](/filings/0001213900-25-026222.md) | [13.4](/filings/0001193125-24-142919.md) | [92.5](/filings/0001213900-25-076606.md) | [94.3](/filings/0001213900-25-109195.md) | [83.1](/filings/0001213900-26-036606.md) | [82.0](/filings/0001213900-26-056693.md) | [89.9](/filings/0001213900-26-088660.md) | [100](/filings/0001213900-25-109195.md) | [101](/filings/0001213900-26-088660.md) | [101](/filings/0001213900-26-056693.md) | [107](/filings/0001213900-26-088660.md) |
| Current liabilities | $m | [3.4](/filings/0001193125-23-281655.md) | [1.8](/filings/0001213900-25-026222.md) | not reported | not reported | not reported | [2.4](/filings/0001213900-26-036606.md) | [2.2](/filings/0001213900-25-044162.md) | [3.3](/filings/0001213900-25-076606.md) | [18.2](/filings/0001213900-25-109195.md) | [19.0](/filings/0001213900-26-088660.md) | [20.5](/filings/0001213900-26-056693.md) | [22.0](/filings/0001213900-26-088660.md) |
| Total liabilities | $m | [3.4](/filings/0001193125-23-281655.md) | [32.5](/filings/0001213900-25-026222.md) | [3.5](/filings/0001193125-24-142919.md) | [4.0](/filings/0001213900-24-073913.md) | [4.2](/filings/0001213900-24-097353.md) | [33.3](/filings/0001213900-26-036606.md) | [34.1](/filings/0001213900-25-044162.md) | [37.6](/filings/0001213900-25-076606.md) | [41.7](/filings/0001213900-25-109195.md) | [42.6](/filings/0001213900-26-088660.md) | [40.6](/filings/0001213900-26-056693.md) | [41.4](/filings/0001213900-26-088660.md) |
| Shareholders' equity | $m | [(3.1)](/filings/0001213900-24-097353.md) | [(151)](/filings/0001213900-25-026222.md) | [(3.3)](/filings/0001213900-24-097353.md) | [(3.9)](/filings/0001213900-24-097353.md) | [(4.1)](/filings/0001213900-24-097353.md) | [49.8](/filings/0001213900-26-088660.md) | [47.8](/filings/0001213900-26-088660.md) | [52.3](/filings/0001213900-26-088660.md) | [58.3](/filings/0001213900-25-109195.md) | [58.7](/filings/0001213900-26-088660.md) | [60.7](/filings/0001213900-26-088660.md) | [65.9](/filings/0001213900-26-088660.md) |

- Cash and equivalents: us-gaap:Cash, us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Shareholders' equity: us-gaap:StockholdersEquity, us-gaap:StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.3) d](/filings/0001213900-24-097353.md) | [(5.0) d](/filings/0001213900-25-026222.md) | [(2.4)](/filings/0001213900-25-044162.md) | [(2.3) d](/filings/0001213900-25-076606.md) | [(2.2) d](/filings/0001213900-25-109195.md) | [(10.0) d](/filings/0001213900-26-036606.md) | [(1.9)](/filings/0001213900-26-056693.md) | [(0.7) d](/filings/0001213900-26-088660.md) | [9.0 d](/filings/0001213900-25-109195.md) | [3.7 d](/filings/0001213900-26-036606.md) | [2.9](/filings/0001213900-26-056693.md) | [4.2 d](/filings/0001213900-26-088660.md) |
| Share repurchases | $m | [0.0 d](/filings/0001213900-24-097353.md) | [0.0 d](/filings/0001193125-24-083443.md) | [11.3](/filings/0001193125-24-142919.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2024 (2024-03-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [33.5](/filings/0001213900-25-044162.md) | [40.6](/filings/0001213900-26-056693.md) | [40.6](/filings/0001213900-26-088660.md) | [40.6](/filings/0001213900-25-109195.md) | [40.7](/filings/0001213900-26-056693.md) | [40.9](/filings/0001213900-26-088660.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 4,589,913 at 2024-11-08, from the cover of the [10-Q filed 2024-11-13](/filings/0001213900-24-097353.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.